Below are the most recent publications written about "Pyrimidines" by people in Profiles.
-
Bochenek MA, Farah S, Doloff JC, Han HJ, Sadraei A, Jeang WJ, Shaheen-Mualim M, Kutner N, Odeh E, Facklam A, DiNardo A, Engquist EN, Rios P, Isa D, Ghani S, Joshi I, Xing Y, Wang Y, Pop R, Greiner DL, Oberholzer J, Langer R, Anderson DG. Crystallized colony-stimulating factor-1 receptor inhibitor protects immunoisolated allo but not xeno transplants in primates. Sci Transl Med. 2026 Jan 28; 18(834):eadt1055.
-
Endaya BB, Kucera L, Le DT, Spinelli JB, Bro?kov? A, Lupt?kov? D, Kl?ma K, Oliveira GL, Brisudov? P, Boh?cov? K, Boukalov? ?, Zobalov? R, Kol?r F, Chalupsky K, Dohnalov? K, Yarmohammadi-Barzegar A, Dvor?kov? ?, Biryukova E, Kaliaeva M, Havl?cek V, Sedl?cek R, Proch?zka J, V?tek L, Park S, Mart?sek P, Kr?ka Z, Oliveira PJ, Berridge MV, Neu?il J. Regenerating liver uses ammonia to support de novo pyrimidine synthesis and cell proliferation. Nat Commun. 2025 Nov 04; 16(1):9664.
-
Magesh RY, Kaur AN, Keller FN, Frederick A, Tseyang T, Haley JA, Rivera-Nieves AM, Liang AC, Guertin DA, Spinelli JB, Elledge SJ, Watson EV. Aneuploidy generates enhanced nucleotide dependency and sensitivity to metabolic perturbation. Genes Dev. 2025 06 02; 39(11-12):770-786.
-
Hasanvand A, Ghandinezhad M, Nourmohammadi M, Hatami F, Beiranvand B, Haghighatian Z, Amanolahi Baharvand P, Kharazmkia A. Investigating the role of the AMPK signaling pathway in preventing CCI-induced neuropathy in rats: focus on anti-inflammatory effects. Neurol Res. 2025 Jun; 47(6):494-503.
-
Arowosegbe A, Guo Z, Vanderleeden E, Derr AG, Wang JP. Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats. J Autoimmun. 2025 Feb; 151:103358.
-
Wang Y, Fu Q, Sha S, Yoon S. Interferon inhibitors increase rAAV production in HEK293 cells. J Biotechnol. 2025 Mar; 399:9-18.
-
Harrold LR, Bingham CO, Pope JE, O'Brien J, Moore PC, Roberts-Toler C, Yu M, Sweet LL, Shelbaya A, Masri KR. Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry. Clin Rheumatol. 2025 Feb; 44(2):635-648.
-
Collins SP, Shotwell MS, Strich JR, Gibbs KW, de Wit M, Files DC, Harkins M, Hudock K, Merck LH, Moskowitz A, Apodaca KD, Barksdale A, Safdar B, Javaheri A, Sturek JM, Schrager H, Iovine NM, Tiffany B, Douglas I, Levitt J, Ginde AA, Hager DN, Shapiro N, Duggal A, Khan A, Lanspa M, Chen P, Gentile N, Harris E, Gong M, Sellers S, Goodwin AJ, Tidswell MA, Filbin M, Desai N, Guti?rrez F, Estrada V, Burgos J, Boyles T, Pa?o-Pardo JR, Hussen N, Rosenberg Y, Troendle J, Bernard GR, Bistran-Hall AJ, Walsh K, Casey JD, DeClercq J, Joly MM, Pulley J, Rice TW, Schildcrout JS, Wang L, Semler MW, Self WH. Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical Trial. JAMA Netw Open. 2024 12 02; 7(12):e2448215.
-
Nam M, Xia W, Mir AH, Jerrett A, Spinelli JB, Huang TT, Possemato R. Glucose limitation protects cancer cells from apoptosis induced by pyrimidine restriction and replication inhibition. Nat Metab. 2024 Dec; 6(12):2338-2353.
-
Treaba CA, Herranz E, Barletta VT, Mehndiratta A, Sloane JA, Granberg T, Miscioscia A, Bomprezzi R, Loggia ML, Mainero C. Phenotyping in vivo chronic inflammation in multiple sclerosis by combined 11C-PBR28 MR-PET and 7T susceptibility-weighted imaging. Mult Scler. 2024 Dec; 30(14):1755-1764.